Monitor upcoming quarterly earnings for any fundamental changes. The insider selling is too small to be actionable on its own.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 11 $545.40entry
- T+1 · 5mo ago +0.10%α −0.44% · $545.96
- T+5 · 5mo ago +1.11%α +0.68% · $551.47
- T+20 · 4mo ago +1.30%α −0.59% · $552.48
- T+60 · 2mo ago −10.64%α −15.04% · $487.35
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A small insider selling cluster at United Therapeutics (UTHR) saw the CEO, CFO, and EVP/GCO sell a combined ~$1.23M in open-market shares over a week, but this represents less than 0.01% of the company's $23.5B market cap. The sales follow option exercises and appear routine for tax withholding or liquidity. No material signal for traders.
Key Financial Metrics
Key Facts
- Three insiders sold ~$1.23M in open-market shares, 0.005% of market cap.
- CEO Martine Rothblatt sold 491 shares ($267K), CFO James Edgemond sold 1,565 shares ($853K), EVP Paul Mahon sold 200 shares ($108K).
- All sales occurred after exercising derivative securities, indicating routine tax-related or liquidity-driven transactions.
- Open-market sales were a tiny fraction of the shares acquired via option exercises.
- No significant insider buying or unusual pattern detected.
Financial Impact
Total insider sales of $1.23M, negligible relative to $23.5B market cap.
Risk Factors
- Insider sales could precede negative news, but the scale here is minimal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1781124226769 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers